A small protein known as p11 may play a much broader role in cellular signaling than previously thought. Researchers at Karolinska institutet have now shown that p11 interacts with numerous receptors targeted by commonly used medicines, opening new possibilities for treating conditions such as pain, inflammation and depression. The research is published in the journal Science Advances.
Small Protein p11 May Enhance Cellular Signaling and Open New Treatment Avenues
Researchers at Karolinska Institutet have discovered that the small protein p11 plays a significant role in cellular signaling by interacting with various receptors targeted by common medications. This finding could lead to new treatments for conditions such as pain, inflammation, and depression, which may have implications for healthcare advancements in Iran. The research is published in Science Advances.
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%